Am J Med

1. LU A, Chen CC, Lin C, Wu TJ, et al
   Artificial Intelligence Electrocardiography Detecting Thyrotoxic Periodic Paralysis Following a SARS-CoV-2 Infection.
   Am J Med. 2024 Jan 25:S0002-9343(24)00054-8. doi: 10.1016/j.amjmed.2024.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

2. CLEGG LE, Stepanov O, Schmidt H, Tang W, et al
   Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19.
   Antimicrob Agents Chemother. 2024;68:e0158723.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

3. KAWAI A, Hirata H, Tokunoh N, Ono C, et al
   Adjuvant-free parenterally injectable vaccine platform that harnesses previously induced IgG as an antigen delivery carrier.
   Biochem Biophys Res Commun. 2024;711:149919.
   

   >> Share

   
   
4. BAI G, Zeng X, Zhang L, Wang Y, et al
   Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b.
   Biochem Biophys Res Commun. 2024;712-713:149945.
   

   >> Share

   
   
5. KOMU JG, Jamsransuren D, Matsuda S, Ogawa H, et al
   Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation.
   Biochem Biophys Res Commun. 2024;715:149994.
   

   >> Share

   
   

   
   BMC Pediatr

6. OGILVIE RP, Layton JB, Lloyd PC, Jiao Y, et al
   Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study.
   BMC Pediatr. 2024;24:276.
   

   >> Share

   
   

   
   BMJ

7. 
   Seven days in medicine: 24-30 April 2024.
   BMJ. 2024;385:q969.
   

   >> Share

   
   
8. LANG K
   What do we know about covid-19's effects on the gut?
   BMJ. 2024;385:q842.
   

   >> Share

   
   
9. MCCARTNEY M, Liu PJ, Fearfull A, Macdonald H, et al
   Early diagnosis is not always an unmitigated good, we need to make it useful for patients and clinicians.
   BMJ. 2024;385:q973.
   

   >> Share

   
   
10. TANNE JH
    US pregnant workers get new legal protections, but not paid time off.
    BMJ. 2024;385:q926.
    

    >> Share

    
    
11. MAHASE E
    Doctors will shape Labour's 10 year plan to fix NHS crisis, says shadow health secretary.
    BMJ. 2024;385:q980.
    

    >> Share

    
    
12. SILLETT JM
    Perhaps politicians and health leaders could #sayhellotopatients?
    BMJ. 2024;385:q976.
    

    >> Share

    
    
13. MATHEW R
    Rammya Mathew: We can't overlook the backdrop as Britain becomes "a sicker nation".
    BMJ. 2024;385:q956.
    

    >> Share

    
    
14. WISE J
    MP resigns from Tory party over NHS "stretched close to breaking point".
    BMJ. 2024;385:q983.
    

    >> Share

    
    
15. MIDDLETON J, Saunders P
    What will it take for a new sanitary revolution in the UK?
    BMJ. 2024;385:q974.
    

    >> Share

    
    
16. MORGAN SG
    When will Canada have national pharmacare?
    BMJ. 2024;385:q887.
    

    >> Share

    
    

    
    Epidemiol Infect

17. CHAMBERS T, Anglemyer A, Chen A, Atkinson J, et al
    Population and contact tracer uptake of New Zealand's QR-code-based digital contact tracing app for COVID-19.
    Epidemiol Infect. 2024;152:e66.
    

    >> Share

    
    

    
    J Gen Virol

18. AHRENS AK, Jonsson SR, Svansson V, Brugger B, et al
    Iceland: an underestimated hub for the spread of high-pathogenicity avian influenza viruses in the North Atlantic.
    J Gen Virol. 2024;105.
    

    >> Share

    
    

    
    J Infect

19. CANE J, Sanderson N, Barnett S, Vaughan A, et al
    Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23.
    J Infect. 2024 Apr 29:106164. doi: 10.1016/j.jinf.2024.106164.
    

    >> Share

    
    
20. PINANA M, Gonzalez-Sanchez A, Andres C, Vila J, et al
    Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.
    J Infect. 2024 Apr 6:106153. doi: 10.1016/j.jinf.2024.106153.
    

    >> Share

    
    
21. CAINI S, Casalegno JS, Rodrigues AP, Lee V, et al
    Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study.
    J Infect. 2024;88:106154.
    

    >> Share

    
    
22. COLSON P, Chaudet H, Delerce J, Pontarotti P, et al
    Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic.
    J Infect. 2024 Apr 1:106150. doi: 10.1016/j.jinf.2024.106150.
    

    >> Share

    
    
23. GAYLIS NB, Yang OO
    Understanding immune dysregulation in post-acute sequelae of COVID-19 (PASC) - The hunt for effective treatments.
    J Infect. 2024 Mar 24:106146. doi: 10.1016/j.jinf.2024.106146.
    

    >> Share

    
    
24. SALMAN M, Rana MS, Usman M, Tahir M, et al
    Re-emergence of Diphtheria after COVID-19 Pandemic in Pakistan: time to consider booster vaccination strategies.
    J Infect. 2024 Mar 19:106141. doi: 10.1016/j.jinf.2024.106141.
    

    >> Share

    
    
25. POWELL AA, Dowell AC, Moss P, Ladhani SN, et al
    Current state of COVID-19 in children: 4 years on.
    J Infect. 2024 Mar 1:106134. doi: 10.1016/j.jinf.2024.106134.
    

    >> Share

    
    

    
    J Infect Dis

26. BI Q, Dickerman BA, Nguyen HQ, Martin ET, et al
    Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.
    J Infect Dis. 2024 Apr 30:jiae220. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol Methods

27. KRUNKOSKY M, Krunkosky TM, Meliopoulos V, Kyriakis CS, et al
    Establishment of Swine Primary Nasal, Tracheal, and Bronchial Epithelial Cell Culture Models for the Study of Influenza Virus Infection.
    J Virol Methods. 2024 Apr 26:114943. doi: 10.1016/j.jviromet.2024.114943.
    

    >> Share

    
    
28. AN SH, Kim NY, Heo GB, Kang YM, et al
    Development and evaluation of a multiplex real-time RT-PCR assay for simultaneous detection of H5, H7, and H9 subtype avian influenza viruses.
    J Virol Methods. 2024;327:114942.
    

    >> Share

    
    

    
    Lancet

29. MARCHALIK D, Rehm D
    On not cutting corners.
    Lancet. 2024;403:1623.
    

    >> Share

    
    
30. GREEN A
    Tobias Welte.
    Lancet. 2024;403:1626.
    

    >> Share

    
    

    
    N Engl J Med

31. UYEKI TM, Milton S, Abdul Hamid C, Reinoso Webb C, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.
    N Engl J Med. 2024 May 3. doi: 10.1056/NEJMc2405371.
    

    >> Share

    
    

    
    Pediatrics

32. DEWALD F, Steger G, Fish I, Torre-Lage I, et al
    SARS-CoV-2 Test-to-Stay in Daycare.
    Pediatrics. 2024;153:e2023064668.
    

    >> Share

    
    
33. SENTER JP, Aisenberg LK, Dudley JW, Luan X, et al
    COVID-19 and Asthma Onset in Children.
    Pediatrics. 2024 Apr 12:e2023064615. doi: 10.1542/peds.2023-064615.
    

    >> Share

    
    
34. SAPER JK, Heffernan M, Simon NE, Davis MM, et al
    RSV Vaccination Intention Among People Who Are or Plan to Become Pregnant.
    Pediatrics. 2024 Apr 25:e2023065140. doi: 10.1542/peds.2023-065140.
    

    >> Share

    
    

    
    PLoS Med

35. JUNG SM, Loo SL, Howerton E, Contamin L, et al
    Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub.
    PLoS Med. 2024;21:e1004387.
    

    >> Share

    
    

    
    PLoS One

36. CHEN C, Martins M, Nooruzzaman M, Yettapu D, et al
    Spatial and temporal clustering of anti-SARS-CoV-2 antibodies in Illinois household cats, 2021-2023.
    PLoS One. 2024;19:e0299388.
    

    >> Share

    
    
37. HUA MJ, Butera G, Akinyemi O, Porterfield D, et al
    Biases and limitations in observational studies of Long COVID prevalence and risk factors: A rapid systematic umbrella review.
    PLoS One. 2024;19:e0302408.
    

    >> Share

    
    
38. CHIRAPAPAISAN N, Eiamsamarng A, Chuenkongkaew W, Rattanathamsakul N, et al
    The prone position in COVID-19 impacts the thickness of peripapillary retinal nerve fiber layers and macular ganglion cell layers.
    PLoS One. 2024;19:e0300621.
    

    >> Share

    
    
39. YUSPAHRUDDIN A, Abbas H, Pahala I, Eliyana A, et al
    Fostering proactive work behavior: Where to start?
    PLoS One. 2024;19:e0298936.
    

    >> Share

    
    
40. AMIO MGA, Ahmed HN, Ali SM, Ahmed S, et al
    Key determinants to supply chain resilience to face pandemic disruption: An interpretive triple helix framework.
    PLoS One. 2024;19:e0299778.
    

    >> Share

    
    
41. YUAN JL, Jing N
    The financial risk of real estate combined factor analysis with grey prediction in Liaoning Province.
    PLoS One. 2024;19:e0301526.
    

    >> Share

    
    
42. DEWI PEN, Sunantiwat M, Thavorncharoensap M, Youngkong S, et al
    Treatment seeking experiences of ACS patients in Yogyakarta, Indonesia during COVID-19 pandemic: A qualitative study.
    PLoS One. 2024;19:e0302320.
    

    >> Share

    
    
43. ASUMADU ODK, Boah M, Chirawurah D, Ndago JA, et al
    Pregnancy outcomes before and during COVID-19 pandemic in Tamale Metropolis, Ghana: A retrospective cohort study.
    PLoS One. 2024;19:e0302589.
    

    >> Share

    
    
44. ZHOU X, Huang T, Pan H, Du A, et al
    Bioinformatics and system biology approaches to determine the connection of SARS-CoV-2 infection and intrahepatic cholangiocarcinoma.
    PLoS One. 2024;19:e0300441.
    

    >> Share

    
    
45. MARTINS P, Luzia RWS, Filho JAP, Welsh KS, et al
    Prevalence and factors associated with burnout among health professionals of a public hospital network during the COVID-19 pandemic.
    PLoS One. 2024;19:e0298187.
    

    >> Share

    
    
46. VRABCOVA P, Scholz P, Linderova I, Kotouckova H, et al
    Eco-friendly hotels and guesthouses as a new opportunity for resilience and sustainability: Evidence from the Czech Republic.
    PLoS One. 2024;19:e0301936.
    

    >> Share

    
    
47. HALL V, Cardona C, Mendoza K, Torchetti M, et al
    Surveillance for highly pathogenic avian influenza A (H5N1) in a raptor rehabilitation center-2022.
    PLoS One. 2024;19:e0299330.
    

    >> Share

    
    
48. TAMARGO JA, Martin HR, Diaz-Martinez J, Delgado-Enciso I, et al
    Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida.
    PLoS One. 2024;19:e0297327.
    

    >> Share

    
    
49. YAMAJI T, Harada T, Hashimoto Y, Nakano Y, et al
    Effects of BNT162b2 mRNA Covid-19 vaccine on vascular function.
    PLoS One. 2024;19:e0302512.
    

    >> Share

    
    
50. HWANG LA, Vaithilingam S, Ng JWJ, Nair M, et al
    The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.
    PLoS One. 2024;19:e0301383.
    

    >> Share

    
    
51. WEIGOLD S, Schorr SG, Faust A, Woydack L, et al
    Informed consent and trial prioritization for clinical studies during the COVID-19 pandemic. Stakeholder experiences and viewpoints.
    PLoS One. 2024;19:e0302755.
    

    >> Share

    
    
52. JANNAT Z, Das H, Ali MW, Wahed T, et al
    Disparities in COVID-19 vaccine uptake among rural hard-to-reach population and urban high-risk groups of Bangladesh.
    PLoS One. 2024;19:e0302056.
    

    >> Share

    
    
53. ZHANG R, Byrd T, Qiao S, Torres ME, et al
    Maternal care utilization and provision during the COVID-19 pandemic: Voices from minoritized pregnant and postpartum women and maternal care providers in Deep South.
    PLoS One. 2024;19:e0300424.
    

    >> Share

    
    
54. DAVINA-NUNEZ C, Perez S, Cabrera-Alvargonzalez JJ, Rincon-Quintero A, et al
    Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern.
    PLoS One. 2024;19:e0289188.
    

    >> Share

    
    
55. ESPER TREML R, Caldonazo T, Barlem Hohmann F, Lima da Rocha D, et al
    Association of chest computed tomography severity score at ICU admission and respiratory outcomes in critically ill COVID-19 patients.
    PLoS One. 2024;19:e0299390.
    

    >> Share

    
    
56. HU Y, Villalan AK, Fan X, Zhang S, et al
    Analysis the molecular similarity of least common amino acid sites in ACE2 receptor to predict the potential susceptible species for SARS-CoV-2.
    PLoS One. 2024;19:e0293441.
    

    >> Share

    
    
57. ASSCHE SB, Ferraccioli F, Riccetti N, Gomez-Ramirez J, et al
    Urban-rural disparities in COVID-19 hospitalisations and mortality: A population-based study on national surveillance data from Germany and Italy.
    PLoS One. 2024;19:e0301325.
    

    >> Share

    
    
58. ZOZMANN H, Schuler L, Fu X, Gawel E, et al
    Autonomous and policy-induced behavior change during the COVID-19 pandemic: Towards understanding and modeling the interplay of behavioral adaptation.
    PLoS One. 2024;19:e0296145.
    

    >> Share

    
    
59. KELEYNIKOV M, Cohen N, Benatov J
    Maternal distress during the COVID-19 outbreak: A socio-ecological perspective.
    PLoS One. 2024;19:e0302266.
    

    >> Share

    
    
60. CHUEMCHIT M, Linn N, Han CPP, Lynn Z, et al
    Discrimination and violence against women migrant workers in Thailand during the COVID-19 pandemic: A mixed-methods study.
    PLoS One. 2024;19:e0300388.
    

    >> Share

    
    
61. ZOU Y, Pan M, Zhou T, Yan L, et al
    Critical COVID-19, Victivallaceae abundance, and celiac disease: A mediation Mendelian randomization study.
    PLoS One. 2024;19:e0301998.
    

    >> Share

    
    
62. NEWMAN PA, Chakrapani V, Massaquoi N, Williams CC, et al
    Effectiveness of an eHealth intervention for reducing psychological distress and increasing COVID-19 knowledge and protective behaviors among racialized sexual and gender minority adults: A quasi-experimental study (#SafeHandsSafeHearts).
    PLoS One. 2024;19:e0280710.
    

    >> Share

    
    
63. CASJENS S, Taeger D, Bruning T, Behrens T, et al
    Changes in mental distress among employees during the three years of the COVID-19 pandemic in Germany.
    PLoS One. 2024;19:e0302020.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

64. MAO T, Kim J, Pena-Hernandez MA, Valle G, et al
    Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract.
    Proc Natl Acad Sci U S A. 2024;121:e2319566121.
    

    >> Share

    
    
65. KUNG CSJ, Steptoe A
    Changes in well-being among socially isolated older people during the COVID-19 pandemic: An outcome-wide analysis.
    Proc Natl Acad Sci U S A. 2024;121:e2308697121.
    

    >> Share

    
    

    
    Vaccine

66. PITTS PJ, Poland GA
    Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic.
    Vaccine. 2024 Apr 10:S0264-410X(24)00396-7. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
67. BAKER J, Aliabadi N, Munjal I, Jiang Q, et al
    Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18-49 years of age: Results of a randomized phase 3 study.
    Vaccine. 2024 Apr 13:S0264-410X(24)00387-6. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
68. DEAL A, Crawshaw AF, Salloum M, Hayward SE, et al
    Understanding the views of adult migrants around catch-up vaccination for missed routine immunisations to define strategies to improve coverage: A UK in-depth interview study.
    Vaccine. 2024 Apr 16:S0264-410X(24)00406-7. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
69. LEE N, Hong Y, Kirkpatrick CE, Hu S, et al
    COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants.
    Vaccine. 2024 Apr 16:S0264-410X(24)00402-X. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
70. PEREIRA ET, Iasulaitis S, Greco BC
    Analysis of causal relations between vaccine hesitancy for COVID-19 vaccines and ideological orientations in Brazil.
    Vaccine. 2024 Apr 16:S0264-410X(24)00436-5. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
71. EJNAR HANSEN M, David Pickering S
    The role of religion and COVID-19 vaccine uptake in England.
    Vaccine. 2024;42:3215-3219.
    

    >> Share

    
    
72. FLEARY SA, Shahn Z, Teasdale CA
    Effects of parental childhood cultural health environment on children's influenza and COVID-19 vaccination status.
    Vaccine. 2024 Apr 29:S0264-410X(24)00515-2. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    

    
    Virology

73. MA X, Wang Q, Xu X, Zhang W, et al
    miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
    Virology. 2024;595:110094.
    

    >> Share

    
    
74. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
    Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Virology. 2024;595:110097.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share